Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Mark Berman, M.D.
WARNING LETTER
•Mark Berman, M.D.•July 13, 2018

Mark Berman, M.D. – FDA Warning Letter, Jul 13, 2018

Record Details

On February 13, 2019, the FDA issued a Warning Letter to Mark Berman, M.D., following a July 9-13, 2018 inspection of his Beverly Hills facility. The inspection revealed that Dr. Berman manufactures and markets the "Pocket Protector," a device intended for use in breast augmentation procedures. The FDA determined this product is a Class III device requiring premarket approval (PMA).

The Pocket Protector is deemed adulterated because Dr. Berman lacks an approved PMA or an approved Investigational Device Exemption (IDE). His IDE application was disapproved in July 2017 due to deficiencies. The device is also misbranded as the firm failed to notify the FDA of its intent to commercially distribute it. The FDA rejected Dr. Berman's assertion that the device qualifies for a custom device exemption, citing failure to submit annual reports, production exceeding five units per year, and non-compliance with other custom device requirements.

The inspection also found the Pocket Protector adulterated due to numerous Quality System (QS) regulation violations (21 CFR Part 820), including: - Failure to establish design control procedures (21 CFR 820.30). - Lack of procedures for controlling purchased products and services (21 CFR 820.50). - Failure to control production processes, including lack of clean rooms, equipment calibration records, and sterilization documentation (21 CFR 8

Company
Mark Berman, M.D.
Inspection date
July 13, 2018
Product type
Devices
Office
Los Angeles District Office
Person
  • Shari J. Shambaugh (Program Division Director)
View Company Profile

ID · 3fd52d59-8878-462f-b5f7-5bca68745fa9

Violation Codes10
21 U.S.C. 321(h)21 U.S.C. 351(b)21 U.S.C. 360j(g)21 U.S.C. 352(o)21 U.S.C. 360(k)21 U.S.C. 351(h)21 CFR 82021 CFR 820.3021 CFR 820.5021 CFR 820.70(a)

Full citation text and observation details available on the Dashboard.

Other documents for Mark Berman, M.D.
  • 483 - 2019-12-05December 5, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Mark Berman, M.D.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.